Latest News of ELVN
Enliven Therapeutics (NASDAQ:ELVN) Is In A Good Position To Deliver On Growth Plans
By Yahoo! Finance |
2 months ago
Investors are drawn to unprofitable companies like Amazon.com, which despite initial losses, saw significant growth. However, such companies pose risks due to potential cash depletion. Examining Enliv...
Enliven Therapeutics, Inc. (ELVN) Stock Price, News, Quote & History
By Yahoo! Finance |
3 months ago
Enliven Therapeutics is a biopharmaceutical company in Boulder, CO, developing small molecule inhibitors for cancer treatment. Their lead products, ELVN-001 and ELVN-002, are in Phase 1 trials for chr...